Portfolio

Director dealings: 4D Pharma board up stakes

By Iain Gilbert

Date: Wednesday 22 May 2019

Director dealings: 4D Pharma board up stakes

(Sharecast News) - 4D Pharma revealed that chief executive Duncan Peyton had acquired 101,199 ordinary shares in the AIM-listed drugmaker on Wednesday.
Peyton, who co-founded equity investment vehicle Aquarius back in 2005, purchased the shares on Tuesday at an average price of 99.40p each, for a total value of £100,592.

Chief scientific officer Alex Stevenson also snapped up some shares on the same day - spending £49,978 on 50,998 ordinary shares at 98p each.

4D Pharma shares dropped on Tuesday after the group warned investors that it would have to tap the market for more money within the next few months.

As of 1635 BST, 4D shares had slipped 2.29% to 98.20p.

Top Director Buys

4D Pharma (DDDD)

Director name: Mr Duncan Joseph Peyton

Amount purchased: 101,199 @ 99.40p

Value: £100,592



Phoenix Global Resources (PGR)

Director name: Mr Sir Michael Rake

Amount purchased: 300,000 @ 22.00p

Value: £66,000



4D Pharma (DDDD)

Director name: Mr Alexander James Stevenson

Amount purchased: 50,998 @ 98.00p

Value: £49,978



JPMorgan Multi-Asset Trust (MATE)

Director name: Sir Laurence Magnus

Amount purchased: 50,000 @ 92.38p

Value: £46,190



SDX Energy Inc. (DI) (SDX)

Director name: Mr Mark Reid

Amount purchased: 84,185 @ 23.76p

Value: £20,002



Top Director Sells

British American Tobacco (BATS)

Director name: Mr Jack Bowles

Amount sold: 6,811 @ 2,947.00p

Value: £200,720

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page